Do Ozempic and Other Weight-Loss Drugs Cause Vision Loss?

Posted: February 21, 2025

Print Friendly, PDF & Email
GLP-1RA Ozempic Wegovy Rybelsus weightloss semaglutide drug lawsuit

#1: A Recent Study Linked Ozempic to Vision Loss.

Recent studies have raised concerns about potential vision-related side effects associated with popular weight-loss and diabetes medications, such as Ozempic and Zepbound. These drugs, classified as GLP-1 receptor agonists (GLP-1 RAs), have been linked to rare eye conditions that could lead to permanent vision impairment.

Learn More
Ozempic Rybelsus Wegovy weightloss drugs semaglutide GLP-1RA

#2. Scientists Studied 9 Cases
of Vision Loss in Weight-Loss Drug Users.

A study published in JAMA Ophthalmology examined 9 cases where patients experienced significant eye issues after being prescribed semaglutide (found in Ozempic and Wegovy) or tirzepatide (found in Mounjaro and Zepbound).

Read More

#3. Rapid Changes in Blood Sugar Caused NAION in Patients.

Among these patients, seven developed non-arteritic anterior ischemic optic neuropathy (NAION), a condition in which reduced blood flow to the optic nerve leads to sudden and often irreversible vision loss. The remaining patients were diagnosed with bilateral papillitis, involving swelling of both optic nerve heads, and paracentral acute middle maculopathy, affecting blood flow in part of the retina.

Researchers suggest that these conditions may result from rapid changes in blood sugar levels induced by the medications, rather than a direct toxic effect of the drugs.

Read More
NAION Ozempic Wegovy Rybelsus weightloss semaglutide drug GLP-1RA

#4. NAION Results From Poor Blood Flow to the Optic Nerve.



Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) is a condition characterized by sudden vision loss due to insufficient blood flow to the optic nerve. The optic nerve is responsible for transmitting visual information from the eye to the brain. When its blood supply is compromised, it can lead to significant visual impairment.

It is a relatively uncommon condition, with an estimated occurrence of 2 to 10 cases per 100,000 individuals annually. However, the condition is most commonly found in patients with obesity, diabetes, and possibly obstructive sleep apnea.

Read More
Ozempic Wegovy Rybelsus GLP-1RA semaglutide weightloss drugs vision loss and vision impairment

#5. Ozempic Users Should Watch for NAION Symptoms.


The hallmark symptom of NAION is sudden, painless vision loss in one eye, often noticed upon waking. This vision loss can manifest as:

* Blurred or Dimmed Vision: A portion of the visual field may appear blurry or darker than usual.

* Visual Field Defects: Commonly, the lower half of the visual field is affected.

* Color Vision Impairment: Colors may appear less vibrant or washed out.

In some cases, individuals may experience a gradual worsening of vision over a period of up to two weeks.

Read More
non-arteritic anterior ischemic optic neuropathy (NAION) Ozempic Rybelsus Wegovy weightloss drug vision loss

#6. An Eye Specialist Can Diagnose NAION.

Diagnosing NAION involves a comprehensive eye examination by an eye care specialist. Key diagnostic steps include:

* Visual Acuity Test: Assessing the clarity of vision

* Visual Field Test: Determining the extent of peripheral vision loss

* Fundoscopic Examination: Inspecting the optic disc for signs of swelling or pallor

* Imaging Tests: Possible optical coherence tomography (OCT) to visualize the optic nerve and assess any structural damage

Read More
Ozempic vision loss Wegovy Rybelsus GLP-1RA semaglutide weightloss drugs

#7. There Is No Cure for NAION.

Currently, there is no definitive cure for NAION. Management focuses on:

* Monitoring: Regular follow-up to assess any changes in vision

* Managing Underlying Conditions: Controlling risk factors such as hypertension, diabetes, and sleep apnea to prevent further episodes

* Vision Rehabilitation: Using visual aids and therapy to maximize remaining vision

If you are experiencing sudden vision changes, it’s crucial that you seek immediate medical attention to determine the cause and start appropriate management.

Read More
lawsuit

#8. People Are Filing Lawsuits for Ozempic-Caused Vision Problems.

In light of these developments, several law firms are filing lawsuits on behalf of individuals who have suffered vision impairment after using GLP-1 RA medications.

These lawsuits allege that manufacturers failed to provide adequate warnings about the potential risk of developing NAION and other serious eye conditions.

Read More
weightloss drugs GLIP-1RA Ozempic Wegovy Rybelsus lawsuit

#9. Meeting Certain Criteria Could Qualify You for a GLP-1RA Drug Vision Impairment Lawsuit.


If you meet the following criteria, you may be eligible to receive compensation:

* Age: You are 75 years old or younger.

* Medication History: You received treatment with brand-name GLP-1 RA drugs, including Ozempic, Wegovy, Rybelsus, Trulicity, Mounjaro, or Zepbound, either in pill form or via injections.

* Medical Diagnosis: You were diagnosed with non-arteritic anterior ischemic optic neuropathy (NAION) while taking the medication.

* Cessation of Medication: You discontinued use of the drug at the time of injury or diagnosis.

* Vision Impairment: You experienced some degree of permanent vision impairment as a result.
Potential claimants are encouraged to seek legal counsel to discuss their specific circumstances and determine eligibility for filing a lawsuit.

Law firms specializing in pharmaceutical litigation can provide guidance on the legal process and potential compensation.

Read More
gastroparesis and GLP 1-RA drugs like Ozempic Wegovy and Rybelsus

# 10. Weight-Loss Drugs Like Ozempic Have Been Linked to Other Injuries.

Beyond vision-related concerns, GLP-1 RA medications have been linked to other serious side effects, notably gastrointestinal issues. Some patients have reported developing gastroparesis, also known as stomach paralysis, after using drugs like Ozempic, Wegovy, and Rybelsus.

Gastroparesis is a condition where the stomach cannot empty itself in the normal way, leading to symptoms like nausea, vomiting, and severe abdominal pain. These symptoms can significantly impact a person’s quality of life and may require ongoing medical treatment.

Legal actions have been initiated on behalf of individuals who have suffered from gastroparesis and other gastrointestinal injuries after using GLP-1 RA medications.

Read More

More Drug Injury News